JAMA Network
About The Study: Supply chain issues associated with drug shortages increased at the beginning of the COVID-19 pandemic according to the results of this national cross-sectional study. Ongoing policy work is needed to protect U.S. drug supplies from future shocks and to prioritize clinically valuable drugs at greatest shortage risk.
Authors: Katie J. Suda, Pharm.D., M.S., of the University of Pittsburgh School of Medicine, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.4246)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
